Barinthus Biotherapeutics plc (BRNS)

NCM – Real vaqt narxi. Valyuta: USD

0.57

-0.00 (-0.40%)

Bozor ochiq: Aug 12, 2026, 11:39 AM EDT

0.56

-0.01 (-2.57%)

Oldingi bozordan keyin: Aug 11, 2026, 4:07 PM EDT

06.08.2026

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing Completed enrollment of 42 planned subjects in the Phase 1 AVALON trial evaluating VTP-1000 in patients with celiac disease; topline data from multiple ascending dose ("MAD") expected in the fourth quarter of 2026 GERMANTOWN, Md., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today announced its financial results for the quarter ended June 30, 2026, and provided an overview of the Company's corporate developments.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Barinthus Biotherapeutics plc (BRNS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Barinthus Biotherapeutics plc (BRNS)

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Videolar

No Data

Press-relizlar

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Videolar

No Data

Press-relizlar

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Search stocks

Barinthus Biotherapeutics plc (BRNS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Barinthus Biotherapeutics plc (BRNS)

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Videolar

No Data

Press-relizlar

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Videolar

No Data

Press-relizlar

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments